Cara F. Dunne - Publications

Transitioning to adult care for patients with IBD: the impact of a structured IBD transition program on service engagement.

Journal: Inflammatory bowel diseases

Published: November 08, 2025

A multi-omic biomarker signature in pre-treatment rectal tumours stratifies patients with different pathological responses to neoadjuvant treatment.

Journal: Clinical and translational medicine

Published: October 23, 2025

FISH-Flow Cytometry Reveals Microbiome-Wide Changes in Post-Translational Modification and Altered Microbial Abundance Among Children with Inflammatory Bowel Disease.

Journal: Pathogens (Basel, Switzerland)

Published: October 07, 2024

Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 24, 2024

Caspase-4 Has Potential Utility as a Colorectal Tissue Biomarker for Dysplasia and Early-Stage Cancer.

Journal: Gastro hep advances

Published: May 14, 2024

Reversal of Intestinal Failure With Teduglutide in PERCC1-Associated Enteropathy: A Case Report.

Journal: Annals of internal medicine

Published: May 06, 2024

Complement is increased in treatment resistant rectal cancer and modulates radioresistance.

Journal: Cancer letters

Published: April 10, 2024

HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: January 12, 2024

Metformin is a metabolic modulator and radiosensitiser in rectal cancer.

Journal: Frontiers in oncology

Published: May 04, 2023

Nonsense mutation in the novel PERCC1 gene as a genetic cause of congenital diarrhea and enteropathy.

Journal: Human genetics

Published: June 20, 2022

Starving for knowledge. Addressing the place of clinical nutrition within undergraduate and postgraduate clinical training: A national survey of practicing clinicians.

Journal: Clinical nutrition ESPEN

Published: April 30, 2022

Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis.

Journal: Intestinal research

Published: May 27, 2021